Academic Journal
Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating Phase I/II-trial
العنوان: | Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating Phase I/II-trial |
---|---|
المؤلفون: | Buhmann, Raymund, Michael, Stanglmaier, Juergen, Hess, Horst, Lindhofer, Peschel, Christian, Kolb, Hans-Jochem |
بيانات النشر: | Springer Nature |
سنة النشر: | 2013 |
المجموعة: | Munich University of Technology (TUM): mediaTUM |
مصطلحات موضوعية: | info:eu-repo/classification/ddc |
نوع الوثيقة: | article in journal/newspaper |
وصف الملف: | application/pdf |
اللغة: | unknown |
Relation: | https://mediatum.ub.tum.de/1510513; https://mediatum.ub.tum.de/doc/1510513/document.pdf |
DOI: | 10.1186/1479-5876-11-160 |
الاتاحة: | https://mediatum.ub.tum.de/1510513 https://mediatum.ub.tum.de/doc/1510513/document.pdf https://doi.org/10.1186/1479-5876-11-160 |
Rights: | info:eu-repo/semantics/openAccess |
رقم الانضمام: | edsbas.7D29E2AF |
قاعدة البيانات: | BASE |
DOI: | 10.1186/1479-5876-11-160 |
---|